slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 93,481-93,510
Pages 3,683
Rows per page 30
Component
93,481-93,510 of 110,471
113
Uses a dot-matrix style comparison to highlight skill gaps.Blackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
06
The slide uses a rhetorical question as a title to frame the data as evidence of a conflict of interest.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Analogy1 hit
07
The slide uses a grid layout to present six key executives, each with their name, title, and a list of logos representing their past professional experience.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Problem (Identify pain)1 hit
20
Uses a 'Whac-a-Mole' analogy to illustrate the limitations of current targeted therapies versus the company's proposed solution.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
22
The slide uses a telescope metaphor to represent the 'Spyglass' platform, focusing on ecDNA biology.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
27
The slide uses a combination of a CRISPR screen scatter plot and a biological process diagram to illustrate the mechanism.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
29
Includes kinase selectivity tree and four tumor volume growth inhibition charts.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
33
The slide highlights the 60mg dose as the MTD (Maximum Tolerated Dose) and shows it crosses the threshold for tumor regression.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
34
The table uses a grid layout to show AE frequency across different dosage cohorts (20mg, 40mg, 60mg, 80mg Q2D, 80mg 2ON/5OFF, 120mg 2ON/5OFF).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
35
Includes legend for dose cohorts and patient IDs; visual evidence of biomarker induction via IHC staining.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
39
The slide uses a biological mechanism diagram to explain the therapeutic rationale for BBI-825.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
42
Includes FISH images, bar chart of copy number, Western blot, and a cell growth curve.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
09
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · Market SizeLoop · Golden Circle1 hit
10
The slide uses a Kaplan-Meier curve to visually demonstrate the 'problem' (rapid progression) and a callout box to quantify the market opportunity.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
12
Includes Kaplan-Meier survival curves and a summary table of clinical outcomes.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
15
Kaplan-Meier survival curve shown.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
18
The slide uses a biological schematic to explain the mechanism of action and key design features of the therapeutic candidate.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
06
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
07
Uses a comparative diagram to illustrate the biological mechanism.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
13
The slide uses a process flow that transitions into a decision tree/matrix based on risk levels.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The slide highlights the regulatory environment as a key driver for development, citing specific FDA definitions and successful approvals.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
15
The slide uses a hierarchical tree structure to map clinical trials to specific patient segments (Intermediate vs High Risk, BCG-naïve/exposed/unresponsive).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
17
BOND-003 study data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
19
The slide uses a swimmer plot to visualize individual patient response durations, including complete response, recurrence, and reinduction events.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
20
BOND-003 clinical trial safety data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
28
The slide uses a hierarchical tree structure to map patient risk categories to specific clinical trial programs (PIVOT-006, CORE-008, BOND-003, CORE-001).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
30
The slide uses a grid of four headshots with biographical details and company logos for each member.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
31
The slide uses a circular process flow graphic to represent a sequential commercialization strategy.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
04
Focuses on power cost, energy stability, and fleet efficiency improvements alongside specific data center expansion timelines.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations 1 hit
05
The slide uses a process flow diagram to explain the mining ecosystem and a list of key metrics to define the economics.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations 1 hit